Taevas
Taevas Global delivers integrated, end to end marketing support across every stage of your commercial journey — from strategy and content to channel activation and performance tracking — across 120+ global markets.
End To End Marketing Support is a fully integrated service that covers every commercial touchpoint in the life sciences value chain — from brand strategy and scientific communication to distributor enablement, digital campaigns, and measurable market outcomes. It eliminates the fragmentation of working with multiple agencies by placing every function under a single, accountable partner.
Taevas Global approaches End To End Marketing Support with deep sector expertise and a global operational footprint. Our teams combine regulatory awareness, clinical understanding, and commercial acumen to build marketing ecosystems that resonate with doctors, hospital procurement teams, and distribution networks simultaneously — ensuring consistent messaging and accelerated market penetration.
One partner. Every market. Measurable commercial impact across the full life sciences value chain.
We develop science-backed brand architectures that differentiate your product in crowded therapeutic categories and resonate with clinical audiences globally.
Our medical writers and regulatory specialists produce compliant, evidence-based content — from monographs and dossiers to promotional materials — tailored to each market.
We design and execute integrated campaigns across digital, print, congress, and field channels, coordinating every touchpoint for maximum reach and consistency.
We equip your distribution network with the tools, training, and marketing assets they need to convert awareness into orders at every level of the supply chain.
Our six-pillar framework ensures no commercial gap is left unaddressed — from the first strategic insight to sustained in-market performance.
Every effective campaign begins with rigorous market understanding. We conduct primary and secondary research across target geographies to map competitive landscapes, patient pathways, prescriber behaviors, and procurement dynamics. These insights form the strategic foundation for every downstream marketing decision.
Life sciences marketing operates within strict regulatory boundaries that vary by market. Our compliance specialists integrate local regulatory requirements into every piece of content and campaign material, ensuring promotional claims are substantiated, approved, and audit-ready across all target markets.
We translate complex clinical data into compelling, audience-appropriate narratives for physicians, procurement officers, and distributors. From visual identity and messaging frameworks to medical education materials and congress presentations, we build brands that earn clinical trust.
Our digital teams deploy targeted campaigns across HCP portals, medical platforms, LinkedIn, programmatic networks, and email — coordinated with field force and event strategies. Every channel is optimized for the specific audience segment and market maturity level.
For new product launches and market expansions, we provide end to end launch support including pricing strategy input, key opinion leader engagement, distributor onboarding, and localized campaign rollout across multiple geographies simultaneously.
We establish KPI frameworks aligned to your commercial objectives and deliver real-time dashboards tracking campaign performance, HCP engagement, distributor sell-through, and market share progression. Regular optimization cycles ensure budgets are allocated to the highest-impact activities.
A structured four-stage process that balances speed with rigour — typically complete in 4–6 weeks.
We align on objectives, geographies, therapy areas, and the specific business questions that need answering.
A 30–45 minute scoping call establishes the intelligence framework — ensuring every subsequent research hour is focused on decisions that matter.
Our End To End Marketing Support is purpose-built for each life sciences sector, reflecting the distinct regulatory, clinical, and commercial dynamics of each industry.
From branded generics to biologics, we cover the full pharmaceutical value chain — clinical pipeline tracking, patent cliff analysis, and reimbursement modelling across regulated and emerging markets.
Our End To End Marketing Support operates across every major life sciences market, with in-region teams and local regulatory knowledge ensuring campaigns land with precision and compliance.
India · China · Japan · South Korea · Australia · Indonesia · Thailand · Vietnam · Philippines
Germany · France · UK · Italy · Spain · Netherlands · Switzerland · Poland · Sweden
United States · Canada · Brazil · Mexico · Colombia · Argentina · Chile
UAE · Saudi Arabia · Turkey · Israel · Egypt · Qatar
South Africa · Nigeria · Kenya · Ethiopia · Morocco
Bangladesh · Sri Lanka · Pakistan · Nepal · Myanmar
Every End To End Marketing Support mandate includes a comprehensive suite of strategic, creative, and analytical deliverables — no hidden add-ons, no fragmented handoffs.
TAM/SAM/SOM with 5-year projections, segmented by product type, end user, and geography.
Profiling of top 10–15 players with pipeline, financials, positioning, and SWOT analysis.
Step-by-step approval guide, typical timelines, required dossiers, and local partner requirements.
Benchmark pricing across channels, reimbursement eligibility, and HTA decision landscape.
Prioritised strategy with recommended partnerships, channels, and launch sequencing.
Key opinion leaders, payer organisations, and the distributor ecosystem across target markets.
Interactive data visualisation summarising findings for C-suite and board presentations.
Post-delivery support to clarify findings, run scenario analyses, or refine recommendations.
End To End Marketing Support is designed for the full spectrum of commercial leaders in life sciences who need a single, accountable partner to drive growth across complex markets.
Evaluating new market entry, product launches in new geographies, or acquisitions requiring deep commercial due diligence.
Conducting commercial due diligence, validating market size assumptions, or assessing competitive moats before committing capital.
Seeking investor-grade market data to underpin fundraising narratives, identify first-mover opportunities, or prioritise expansion.
Understanding sector landscapes, benchmarking policy environments, and identifying foreign investment opportunities in health and life sciences.
Translating academic research into commercial potential assessments, technology transfer opportunities, and licensing strategy.
White-label intelligence support for strategy and management consulting firms advising clients across life sciences markets.
Our analysts work exclusively in pharma, medtech, and consumer health. Every report reflects deep domain expertise — not generic research methodology applied to healthcare.
We don’t just aggregate public data. Every engagement includes primary interviews with regulators, KOLs, payers, and channel partners — intelligence you can’t Google.
Our network spans India, Southeast Asia, MENA, and Sub-Saharan Africa — markets that generic firms cover superficially but where the greatest growth opportunities exist.
We write for decision-makers, not archives. Every report includes a clear recommendation. Our readout sessions are structured for board discussions, not just information transfer.
Rapid-response turnarounds of 2–4 weeks for focused engagements — without sacrificing the rigour of primary research and expert validation.
Our 30-day Q&A window, ongoing subscriptions, and retainer models mean we’re a long-term intelligence partner — not a one-off vendor.
“Taevas delivered a fully integrated marketing program across eight markets in under three months — from brand strategy to distributor activation — with a level of regulatory precision and commercial acumen we had not found in any single partner before.”
End To End Marketing Support is your commercial foundation — pair it with these complementary Taevas services to maximize market impact and strategic depth.
From regulatory pathway mapping to full dossier preparation and submission management across global markets.
Shortlisting, evaluating, and connecting you with validated in-market partners, distributors, and licensing candidates.
Optimise launch pricing, reimbursement positioning, and access pathways to maximise commercial success from day one.
Scientific communication strategy, publication planning, and structured KOL engagement programmes for new market entrants.
Investor-grade commercial assessments for M&A, licensing deals, or fundraising — with rapid turnaround for live transactions.
Monthly or quarterly market monitoring — competitive signals, regulatory updates, and commercial developments as a managed service.
Partner with Taevas Global to build a fully integrated marketing engine for your life sciences portfolio — covering every audience, every channel, and every market you need to win.